HONG KONG SAR - EQS Newswire - 30 December 2025 - Uni-Bio Science Group Limited ("Uni-Bio Science Group", "Uni-Bio" or "the ...
BSF Enterprise PLC (LSE:BSFA) (the "Company"), a leading innovator in tissue-engineered materials, is pleased to announce that its subsidiary company 3D Bio-Tissues (3DBT) has signed a Head of Terms ...
“TY1 is the first exomer – a new class of drugs that address tissue damage in unexpected ways.” TY1 has the structure of existing RNA drugs, and works like its natural version – amplifying the ...
Light chain amyloidosis is not cancer, but cancer drugs are this rare disease’s standard of care. The patient need for new treatment options has sparked R&D efforts at biotech and big pharmaceutical ...
The MarketWatch News Department was not involved in the creation of this content. Targeting the Root Causes of Aging Demonstrates Powerful Anti-Cancer Activity Across Multiple Tumor Models MIAMI BEACH ...
Precise Bio has reported the first successful human implantation of its 3D-printed cornea implant, constructed of functional human eye cells cultured in a laboratory. The company described the ...
The use of B-cell–depleting antibodies for autoimmune disease has been well validated with significant use of Roche Holdings AG (OTC:RHHBY) and Biogen Inc (NASDAQ:BIIB) partnered Rituxan (rituximab) ...
SOUTH SAN FRANCISCO, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene ...
Scientists have uncovered a surprisingly simple “tissue code”: five rules that choreograph when, where, and how cells divide, move, and die, allowing organs like the colon to remain flawlessly ...
3D bioprinting combines cells, growth factors, and biomaterials to fabricate biomedical parts. The process requires special “bio-inks,” often made of materials like alginate or gelatin. A key goal is ...
Every day, your body replaces billions of cells-and yet, your tissues stay perfectly organized. How is that possible? A team of researchers at ChristianaCare's Helen F. Graham Cancer Center & Research ...